Drug major Dr Reddy's Laboratories is working on the development of new treatment options for Covid-19 patients which it aims to launch over the next few month, the pharma’s Co-Chairman & Managing Director G V Prasad has said. The top official also ensured uninterrupted supplies of its existing range of products for the infectious disease in the market. The drug firm over the past few weeks has ramped up supply of multiple medicines including Remdesivir to meet the surge in demand, he added.
The Hyderabad-based drug major has already launched Sputnik V vaccine while partnering with various organisations, including the Defence Research and Development Organisation.